Leap-In Transposase

Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform

Wheeler Bio

CMC

Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform

Wheeler Bio

Glycosylation

S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach

Junyong Park

Samsung Biologics

Strategic Partnership

Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies

Samsung Biologics

CMC

The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies

Jesse McCool, Ph.D.; David Schmidt, M.B.A., M.Sc.; Oren Beske, Ph.D.; Stephen Monks, Ph.D.

Wheeler Bio

Consulting

Supporting Drug Development – Increasing Probability of Success

Nick Davies; Beth Lindsey; Ian Smart

Verta Life Sciences

Cell and Gene Therapy

State of the Cell and Gene Therapy Market

James Grote

Nice Insight

Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

Jennifer Cheung

WuXi Advanced Therapies

Live Biotherapeutic Products

Framing the Narrative on CMC Development for Microbiome Therapeutics

Aaron B. Cowley, Ph.D.; Melanie Cerullo; Jeff Heiser

Arranta Bio

Chemistry, Manufacturing, and Controls

Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization

Matthew Rota; Lisa Caralli; Jim Spavins

Catalent